Opendata, web and dolomites
H2020 projects about "gbm"
The page lists 29 projects related to the topic "gbm".
| # | |||
|---|---|---|---|
| 1 | GlioVac | Validation of a conceptually new treatment for glioblastoma multiforme with an IP protected small molecule | 2015 |
| 2 | HESPERIA | High Energy Solar Particle Events foRecastIng and Analysis | 2015 |
| 3 | CSC-IS | Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 |
| 4 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
| 5 | HyGlio | Theranostic Injectable Hydrogel for Glioblastoma | 2016 |
| 6 | AVITAG | Alphaviral Immunotherapy against Glioblastoma | 2016 |
| 7 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
| 8 | Lumiblast | A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours | 2016 |
| 9 | GlioDx | GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients | 2016 |
| 10 | iGBMavatars | Glioblastoma Subtype Avatar models for Target Discovery and Biology | 2017 |
| 11 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 12 | BRAINHIB | Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation | 2018 |
| 13 | GLIOMA | Targeting Glioblastoma using Combinatorial Therapeutic Nanovaccine | 2017 |
| 14 | GlimS | Patient-specific tumour growth model for quantification of mechanical 'markers' in malignant gliomas: Implications for treatment outcomes. | 2017 |
| 15 | GLIOTRAIN | Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | 2017 |
| 16 | MaGMa | Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma | 2018 |
| 17 | MITIG | Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism | 2019 |
| 18 | GEiMS | GridEye State Estimation of Medium Voltage Distribution Systems | 2018 |
| 19 | GLIOGUIDE | Commercialising a novel glioblastoma targeted therapy and a companion diagnostic compound | 2018 |
| 20 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 21 | VESSEL CO-COPTION | Vessel co-option and radioresistance in glioblastoma | 2019 |
| 22 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 23 | OncoViroMRI | Brain Cancer Therapy Monitoring using a Novel Quantitative and Rapid Magnetic Resonance Imaging-based Method | 2019 |
| 24 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 25 | Recruit | Origin and Function of Tumor-Associated Macrophages and Mesenchymal Stromal Cells in GBM Subtypes | 2019 |
| 26 | QuiescStemGBM | Studying the role of Quiescent Cancer Stem Cells in GBM development using a novel in vivo cell cycle-based approach | 2020 |
| 27 | CHyMERA | Monitoring cancer heterogeneity based on the dynamic assessment of the Warburg effect under metabolic perturbation | 2019 |
| 28 | Lottare GBM | LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme | 2019 |
| 29 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |